{
  "chunk_id": "chunk_000",
  "category": "blog-fda-gives-thumbs-down-to-tenapanor-for-control-of-phosphorus-in-kidney-pati",
  "file_path": "c:\\Users\\default.LAPTOP-3RO2LG6Q\\Documents\\GitHub\\vector_search\\data\\chunks\\blog-fda-gives-thumbs-down-to-tenapanor-for-control-of-phosphorus-in-kidney-pati\\chunk_000.txt",
  "content": "Dialysis Care Center About DCC Mission and Values The DCC Story Leadership DCC Cares Explore Events Treatments Starting on Dialysis In-Center Hemodialysis Staff-Assisted Dialysis Peritoneal Dialysis Home Hemodialysis Living with Dialysis Diet and Nutrition Blog Feature Stories Careers Explore jobs in USA Menu About DCC Mission and Values The DCC Story Leadership DCC Cares Explore Events Treatments Starting on Dialysis In-Center Hemodialysis Staff-Assisted Dialysis Peritoneal Dialysis Home Hemodialysis Living with Dialysis Diet and Nutrition Blog Feature Stories Careers Explore jobs in USA Admissions Find A Center Find A Center Search Search Close this search box.",
  "url": "https://dccdialysis.com/blog/fda-gives-thumbs-down-to-tenapanor-for-control-of-phosphorus-in-kidney-patients-on-dialysis/",
  "title": "FDA Rejects Tenapanor for Control of Phosphorus in Dialysis"
}